News articles about Cardiovascular Systems (NASDAQ:CSII) have trended somewhat positive on Thursday, according to Accern Sentiment. The research group scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cardiovascular Systems earned a news impact score of 0.05 on Accern’s scale. Accern also assigned news coverage about the medical device company an impact score of 46.4848504411391 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the news articles that may have impacted Accern Sentiment’s rankings:
- Cardiovascular Systems, Inc. to Webcast Fiscal 2018 Third-Quarter Earnings Conference Call Wednesday, May 2 (finance.yahoo.com)
- Cardiovascular Systems (CSII) Rating Increased to Hold at BidaskClub (americanbankingnews.com)
- Cardiovascular Systems, Inc. (CSII) Expected to Post Quarterly Sales of $55.63 Million (americanbankingnews.com)
- -$0.02 Earnings Per Share Expected for Cardiovascular Systems, Inc. (CSII) This Quarter (americanbankingnews.com)
Several research firms have commented on CSII. Zacks Investment Research raised shares of Cardiovascular Systems from a “hold” rating to a “buy” rating and set a $28.00 price target for the company in a research report on Friday, February 9th. William Blair reissued a “market perform” rating on shares of Cardiovascular Systems in a research report on Thursday, December 21st. ValuEngine lowered shares of Cardiovascular Systems from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. BidaskClub raised shares of Cardiovascular Systems from a “sell” rating to a “hold” rating in a research report on Friday, January 26th. Finally, Leerink Swann decreased their price target on shares of Cardiovascular Systems from $31.00 to $30.00 and set an “outperform” rating for the company in a research report on Thursday, February 8th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $27.00.
Cardiovascular Systems (NASDAQ:CSII) last posted its quarterly earnings data on Wednesday, February 7th. The medical device company reported ($0.01) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.04) by $0.03. Cardiovascular Systems had a negative net margin of 1.62% and a negative return on equity of 0.50%. The firm had revenue of $52.63 million for the quarter, compared to the consensus estimate of $53.39 million. During the same quarter in the prior year, the company posted $0.03 earnings per share. The company’s revenue for the quarter was up 5.2% compared to the same quarter last year. analysts anticipate that Cardiovascular Systems will post -0.07 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Cardiovascular Systems (CSII) Earning Somewhat Positive News Coverage, Study Shows” was originally published by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://dakotafinancialnews.com/2018/04/12/cardiovascular-systems-csii-earning-somewhat-positive-news-coverage-study-shows.html.
About Cardiovascular Systems
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.